Tested Applications
| Positive WB detected in | HEK-293 cells, HeLa cells, Jurkat cells |
| Positive IHC detected in | human lung cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
10646-1-AP targets HIF1AN in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag0997 Product name: Recombinant human HIF1AN protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-349 aa of BC007719 Sequence: MAATAAEAVASGSGEPREEAGALGPAWDESQLRSYSFPTRPIPRLSQSDPRAEELIENEEPVVLTDTNLVYPALKWDLEYLQENIGNGDFSVYSASTHKFLYYDEKKMANFQNFKPRSNREEMKFHEFVEKLQDIQQRGGEERLYLQQTLNDTVGRKIVMDFLGFNWNWINKQQGKRGWGQLTSNLLLIGMEGNVTPAHYDEQQNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQSQVDFDNPDYERFPNFQNVVGYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYKGAPTPKRIEYPLKAHQKVAIMRNIEKMLGEALGNPQEVGPLLNTMIKGRYN Predict reactive species |
| Full Name | hypoxia inducible factor 1, alpha subunit inhibitor |
| Calculated Molecular Weight | 40 kDa |
| Observed Molecular Weight | 40 kDa |
| GenBank Accession Number | BC007719 |
| Gene Symbol | HIF1AN |
| Gene ID (NCBI) | 55662 |
| RRID | AB_2232963 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9NWT6 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
HIF1AN (Hypoxia-inducible factor 1-alpha inhibitor) is also named FIH1. It is identified as a molecular oxygen-dependent dioxygenase that blunts the transcriptional activity of HIF and has also been implicated in HIF-dependent and -independent hypoxia responses(PMID:20720525). Structural studies indicate that an FIH-1 homodimer forms in solution and is essential for FIH-1 activity(PMID:16154531).
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for HIF1AN antibody 10646-1-AP | Download protocol |
| WB protocol for HIF1AN antibody 10646-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The HIF1AN Polyclonal antibody (Cat# 10646-1-AP) has 6 total citations published in Bioact Mater, Advanced Science, Cell Death & Disease, Analytical Chemistry, Heliyon, and American Journal of Cancer Research. Research fields span diabetic wound healing via RNAi therapy, AMPK-dependent thermogenic metabolism, cardiac remodeling, proteomic sample preparation, ferroptosis in spinal cord injury, and hepatocellular carcinoma oncogenesis. All citations used the antibody for Western blot applications across human, mouse, and rat species.
| Species | Application | Title |
|---|---|---|
Bioact Mater Development of a novel RNAi therapy: Engineered miR-31 exosomes promoted the healing of diabetic wounds. | ||
Adv Sci (Weinh) Exclusive Breastfeeding Drives AMPK-Dependent Thermogenic Memory in BAT and Promotes Long-Term Metabolic Benefits in Offspring. | ||
Anal Chem A Miniaturized, Automated Proteomic Sample Preparation Platform for High-Throughput Target Deconvolution of Natural Products. | ||
Heliyon LncRNA OIP5-AS1 regulates ferroptosis and mitochondrial dysfunction-mediated apoptosis in spinal cord injury by targeting the miR-128-3p/Nrf2 axis | ||
Am J Cancer Res Experimental and clinical evidence suggests that GRPEL2 plays an oncogenic role in HCC development. |







